New life science research centre to create more than 30 high skilled jobs in Inverness
A new medical technology research and development centre will create more than 30 high skilled jobs in Inverness over the next three years.
With Highlands and Islands Enterprise providing investment of up to £1.75m, life science company ODx will develop and commercialise a test that helps detect the ability of urinary tract infections (UTIs) to resist antibiotics.
ODx has signed a ten-year lease agreement for space in Solasta House, the new £4.5m life sciences building developed by HIE on Inverness Campus, with £1.5m from the European Regional Development Fund.
James Cameron, HIE’s head of life sciences, said: “Inverness and the Highlands and Islands more widely, is increasingly recognised for its growing life sciences sector. ODx is at the heart of this and we are very pleased to welcome the company to the region.
“This exciting new facility fits well with the collaborative and innovative ethos of Inverness Campus. We look forward to working with the company on implementing its plans and to the benefits this will bring, notably the creation of highly-skilled jobs.”
The new research centre will be used to develop and commercialise a test that helps detect the ability of UTIs to resist antibiotics, with ODx aiming to reach faster diagnosis and treatment.
Investment Minister Ivan McKee said: “I welcome ODx decision to establish a medical technology research and development centre in Inverness. The development of this highly specialised facility further builds upon Scotland’s global reputation as a world leading innovator in health technology.
“Highlands and Islands Enterprise are investing up to £1.75 million in this centre, investment which will help create a further 30 highly skilled jobs within three years.
“The Scottish Government and our agencies will continue to support this incredibly important sector, which employs almost 40,000 people across Scotland.”
Holyrood Newsletters
Holyrood provides comprehensive coverage of Scottish politics, offering award-winning reporting and analysis: Subscribe